Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states

被引:369
作者
Agarwal, SK
Kester, MB
Debelenko, LV
Heppner, C
EmmertBuck, MR
Skarulis, MC
Doppman, JL
Kim, YS
Lubensky, IA
Zhuang, ZP
Green, JS
Guru, SC
Manickam, P
Olufemi, SE
Liotta, LA
Chandrasekharappa, SC
Collins, FS
Spiegel, AM
Burns, AL
Marx, SJ
机构
[1] NIDDK, METAB DIS BRANCH, NIH, BETHESDA, MD 20892 USA
[2] NCI, PATHOL LAB, NIH, BETHESDA, MD 20892 USA
[3] NIH, DEPT DIAGNOST RADIOL, BETHESDA, MD 20892 USA
[4] NIH, LAB GENE TRANSFER, BETHESDA, MD 20892 USA
[5] HLTH SCI CTR, DEPT MED GENET, St John, NF A1B 3V6, CANADA
关键词
D O I
10.1093/hmg/6.7.1169
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Familial multiple endocrine neoplasia type 1 (FMEN1) is an autosomal dominant trait characterized by tumors of the parathyroids, gastro-intestinal endocrine tissue, anterior pituitary and other tissues, We recently cloned the MEN1 gene and confirmed its identity by finding mutations in FMEN1, We have now extended our mutation analysis to 34 more unrelated FMEN1 probands and to two related states, sporadic MEN1 and familial hyperparathyroidism, There was a high prevalence of heterozygous germline MEN1 mutations in sporadic MEN1 (8/11 cases) and in FMEN1 (47/50 probands), One case of sporadic MEN1 was proven to be a new MEN1 mutation, Eight different mutations were observed more than once in FMEN1, Forty different mutations (32 FMEN1 and eight sporadic MEN1) were distributed across the MEN1 gene, Most predicted loss of function of the encoded menin protein, supporting the prediction that MEN1 is a tumor suppressor gene, No MEN1 germline mutation was found in five probands with familial hyperparathyroidism, suggesting that familial hyperparathyroidism often is caused by mutation in another gene or gene(s).
引用
收藏
页码:1169 / 1175
页数:7
相关论文
共 31 条
  • [1] ANTONARAKIS SE, 1996, EMERY RIMOINS PRINCI, P53
  • [2] FAMILIAL MULTIPLE ENDOCRINE ADENOMA-PEPTIC ULCER COMPLEX
    BALLARD, HS
    FRAME, B
    HARTSOCK, RJ
    [J]. MEDICINE, 1964, 43 (04) : 481 - +
  • [3] Positional cloning of the gene for multiple endocrine neoplasia-type 1
    Chandrasekharappa, SC
    Guru, SC
    Manickam, P
    Olufemi, SE
    Collins, FS
    EmmertBuck, MR
    Debelenko, LV
    Zhuang, ZP
    Lubensky, IA
    Liotta, LA
    Crabtree, JS
    Wang, YP
    Roe, BA
    Weisemann, J
    Boguski, MS
    Agarwal, SK
    Kester, MB
    Kim, YS
    Heppner, C
    Dong, QH
    Spiegel, AM
    Burns, AL
    Marx, SJ
    [J]. SCIENCE, 1997, 276 (5311) : 404 - 407
  • [4] CHOU YHW, 1995, AM J HUM GENET, V56, P1075
  • [5] COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252
  • [6] Debelenko LV, 1997, CANCER RES, V57, P1039
  • [7] Loss of heterozygosity at 11q13: Analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1
    Dong, QH
    Debelenko, LV
    Chandrasekharappa, SC
    EmmertBuck, MR
    Zhuang, ZP
    Guru, SC
    Manickam, P
    Skarulis, M
    Lubensky, IA
    Liotta, LA
    Collins, FS
    Marx, SJ
    Spiegel, AM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (05) : 1416 - 1420
  • [8] GREEN JS, 1995, THESIS MEMORIAL U NE
  • [9] PRIMARY HYPER-PARATHYROIDISM - INCIDENCE, MORBIDITY, AND POTENTIAL ECONOMIC-IMPACT IN A COMMUNITY
    HEATH, H
    HODGSON, SF
    KENNEDY, MA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (04) : 189 - 193
  • [10] HEATH H, 1993, AM J HUM GENET, V53, P193